CoorsTek 60316 Mortar and 60320 Pestle Set Glazed Porcelain
High-Purity Porcelain for Efficient Grinding and Trituration
Equip your laboratory or compounding pharmacy with this premium CoorsTek 150 mL Mortar (60316) and Pestle (60320) Set. Manufactured from high-quality industrial porcelain, this set is meticulously designed for the rigorous grinding, milling, and crushing of solid chemical samples and pharmaceutical ingredients.
To ensure peak performance, the interior grinding surface of the mortar and the rounded head of the pestle are left unglazed. This provides the optimal friction required to efficiently reduce bulk solids into fine powders or pastes. Conversely, the exterior of the mortar and the handle of the pestle are fully glazed, creating a smooth, non-porous finish that resists cross-contamination and makes cleanup exceptionally easy.
Key Features & Benefits
- Optimal Grinding Friction: The unglazed, roughened interior of the bowl and the unglazed pestle head provide the necessary grip to quickly pulverize tough samples without slipping.
- Easy to Clean: The glazed exterior surfaces prevent sample buildup and chemical absorption, allowing for fast, thorough washing between procedures.
- Thermal & Chemical Resistance: CoorsTek porcelain offers excellent chemical inertness and thermal shock resistance, ensuring safe use with a wide variety of harsh laboratory reagents.
- High-Capacity Processing: The spacious 150 mL volume comfortably accommodates generous sample sizes, making it ideal for bulk compounding, extractions, or general benchwork.
Technical Specifications
| Specification | Details |
|---|---|
| Brand | CoorsTek |
| Mortar Part No. | 60316 |
| Pestle Part No. | 60320 |
| Capacity | 150 mL |
| Material | Industrial Porcelain |
| Finish | Glazed Exterior / Unglazed Grinding Surfaces |
| Quantity Included | 1 Mortar, 1 Pestle |
Used; tested to be in great working condition!
Please note that Life Sciences Trading is not a factory-authorized distributor of the products listed in this store. The items have been acquired as surplus from leading life sciences companies.